Watson Pharmaceuticals, Inc. confirmed that it has filed with the FDA an Abbreviated New Drug Application (ANDA) for Drospirenone and Ethinyl Estradiol and Levomefolate Calcium Tablets, 3.0mg/0.02mg/0.451mg and Levomefolate Calcium Tablets, 0.451mg, a generic version of Bayer HealthCare Pharmaceuticals Inc.'s Beyaz.
Sign in with your MPR account
Keep me signed in Forgot your password?
REGISTER FOR FREE WITH A MPR ACCOUNT
Enter your MPR registration email address to receive a new password.